Head-to-head · WeighScore
Fierce Health vs WePeptideRx
The verdict
WePeptideRx takes it — 61.4/100 to 56.6/100.
WePeptideRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. WePeptideRx is a provider-guided telehealth platform offering compounded semaglutide and tirzepatide alongside a deep menu of peptide, hormone, hair, and sexual-wellness programs.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Fierce Health | WePeptideRx |
|---|---|---|
| WeighScore | 56.6/100 | 61.4/100 |
| Grade | C | C |
| Scorecard rank | #410 | #295 |
| Semaglutide | $297/mo (3-month plan, compounded) | $249/mo (compounded) |
| Tirzepatide | $497/mo (3-month plan, compounded) | $249/mo (compounded) |
| Coverage | 30 states | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #410 · C
Strengths
- 30-state service list spelled out in the Terms — buyers can verify eligibility before intake
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer on every product page
- Four GLP-1 programs (standard and microdose semaglutide and tirzepatide) — a broader ladder than peers
- Microdose tier at $197/mo is one of the lower entry points we've seen
Where it loses points
- No named 503A compounding pharmacy partner — only generic 'partner pharmacies' language
- Operating LLC name not disclosed anywhere on the site
- Tirzepatide weight-loss program ($497/mo) showing 'sold out or unavailable' across all plans at review time
- Clinical provider network not named
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Graded #295 · C
Strengths
- Pre-mixed ready-to-inject delivery skips the vial reconstitution and sharps hassle of most compounded providers
- Microdose protocols (0.05–0.25 mg sema, 0.5–2.5 mg tirz) suit ultra-low-dose maintenance patients — uncommon in DTC
- 12+ programs under one platform — GLP-1 plus longevity, sexual wellness, and hair
- Physical Boca Raton address, phone, and business hours listed
- LegitScript Certified and publishes the FDA disclaimer
Where it loses points
- Pharmacy partner not named
- 48-state claim, but the specific state list isn't shown on the homepage
- Medical director not named on the homepage
- Telemedicine is outsourced to a third-party provider network rather than in-house staff
- Corporate legal entity and arbitration venue not disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.